Abstracts and bio's

Meriem Bouslouk (PhD in dentistry, MSc International Health) joined the Pharmaceuticals department of the Federal Joint Committee (G-BA) in 2011, and has worked on the implementation of AMNOG, the German Act on the Reform of the Market for Medicinal Products, from the start. Her main responsibilities are conducting consultations with industry representatives on clinical study design and appropriate comparators, assessing reports by the Institute for Quality and Efficiency in Health Care (IQWiG), and drafting G-BA resolutions under AMNOG (with an emphasis on orphan drugs) which become amendments to the German Pharmaceutical Directive. Meriem works closely with the voting members of the G-BA and numerous other stakeholders.